In countries such as the UK, US and Australia, strict laws and international conventions prohibiting the use of psychedelic drugs have made it almost impossible to research how these drugs work, and how they might be used to heal instead of harm – until recently. These barriers – together with cost, ethics committees, ideologically driven myths and stigma – have delayed research into a promising area of medicine. But things are changing for the better, as evidence and unmet need are at last being recognised.
Read the full article on The Conversation website, written by Rupert McShane (Consultant Psychiatrist, Department of Psychiatry) and Adam Winstock (University College London).
Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.